Post Feed

PBAC Releases Update on PBS Medicine Review for Multiple Sclerosis

04 Nov 2026

The Pharmaceutical Benefits Advisory Committee (PBAC) has published the outcome statement from its recent stakeholder meeting on medicines for relapsing-remitting multiple sclerosis (RRMS).

The meeting was held on 31 August 2026 as part of a rapid review of medicines listed on the Pharmaceutical Benefits Scheme (PBS) for people living with RRMS.

The meeting's outcome statement has been published on the PBAC Stakeholder Meetings website..

Further details about the review, including its scope, expected timelines and consultation process, can be found on the PBS rapid review website.

PBAC Releases Update on PBS Medicine Review for Multiple Sclerosis

Source: Pharmaceutical Benefits Advisory Committee (PBAC).